STOCK TITAN

AMLX (NASDAQ: AMLX) files Form 144 showing 17,105 RSU shares vesting

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

AMLX Form 144 notice reports proposed transfer related to the vesting of restricted stock units into Common stock. The filing lists 17,105 shares associated with 03/02/2026 and records a sale of 6,580 Common shares by Camille L Bedrosian on 12/01/2025.

Positive

  • None.

Negative

  • None.

Insights

Form 144 documents a proposed disposition tied to RSU vesting and a prior sale by an individual.

The notice lists 17,105 Common shares linked to RSU vesting dated 03/02/2026, which reflects a planned transfer rather than an immediate open-market sale.

It also records a previous sale of 6,580 shares by Camille L Bedrosian on 12/01/2025; timing and execution method for the 03/02/2026 shares are not detailed in the excerpt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does AMLX's Form 144 report say?

It reports a proposed transfer of 17,105 Common shares tied to RSU vesting on 03/02/2026. The form also notes a prior sale of 6,580 Common shares by Camille L Bedrosian on 12/01/2025; transaction mechanics for the 03/02/2026 shares are not included.

Who is the broker or filer listed on the AMLX Form 144?

Morgan Stanley Smith Barney LLC is listed as the broker/filer with an address on 1 New York Plaza. The excerpt identifies the broker name and address but does not add further broker instructions or execution details for the planned transfer.

Does the filing confirm an open-market sale for AMLX shares on 03/02/2026?

The filing shows vesting of RSUs converting to 17,105 Common shares on 03/02/2026, not an explicit open-market sale. The excerpt does not specify sale method, proceeds, or timing of any disposal related to those shares.

What insider activity is recorded for AMLX in the past three months?

The excerpt records a sale of 6,580 Common shares by Camille L Bedrosian on 12/01/2025. This is presented as a prior sale; the Form 144 also lists the separate 03/02/2026 RSU vesting amount of 17,105 shares.
Amylyx Pharmaceuticals

NASDAQ:AMLX

AMLX Rankings

AMLX Latest News

AMLX Latest SEC Filings

AMLX Stock Data

1.65B
92.94M
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE